Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Blemings, Allan"'
Autor:
Melloni, Chiara, Slovin, Susan F., Blemings, Allan, Goodman, Shaun G., Evans, Christopher P., Nilsson, Jan, Bhatt, Deepak L., Zubovskiy, Konstantin, Olesen, Tine K., Dugi, Klaus, Clarke, Noel W., Higano, Celestia S., Roe, Matthew T.
Publikováno v:
In JACC: CardioOncology March 2020 2(1):70-81
Autor:
Rasmussen, Lars, Lawaetz, Martin, Serup, Julie, Bjoern, Lars, Vennits, Bo, Blemings, Allan, Eklof, Bo
Publikováno v:
In Journal of Vascular Surgery: Venous and Lymphatic Disorders October 2013 1(4):349-356
Publikováno v:
In Journal of Vascular Surgery August 2013 58(2):421-426
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laterre, Pierre-François, Berry, Scott, Blemings, Allan, Carlsen, Jan, Francois, Bruno, Graves, Todd, Jacobsen, Karsten, Lewis, Roger, Opal, Steven, Perner, Anders, Pickkers, Peter, Russell, James, Windeløv, Nis, Yealy, Donald, Asfar, Pierre, Bestle, Morten, Muller, Grégoire, Bruel, Cédric, Brule, Noëlle, Decruyenaere, Johan, Dive, Alain-Michel, Dugernier, Thierry, Krell, Kenneth, Lefrant, Jean-Yves, Mégarbane, Bruno, Mercier, Emmanuelle, Mira, Jean-Paul, Quenot, Jean-Pierre, Rasmussen, Bodil Steen, Thorsen-Meyer, Hans-Christian, Vander Laenen, Margot, Vang, Marianne Lauridsen, Vignon, Philippe, Vinatier, Isabelle, Wichmann, Sine, Wittebole, Xavier, Kjolbye, Anne Louise, Angus, Derek
Publikováno v:
JAMA Cardiology
JAMA Cardiology, American Medical Association 2019, 322 (15), pp.1476-1485. ⟨10.1001/jama.2019.14607⟩
JAMA Cardiology, American Medical Association 2019, 322 (15), pp.1476-1485. ⟨10.1001/jama.2019.14607⟩
International audience; Importance: Norepinephrine, the first-line vasopressor for septic shock, is not always effective and has important catecholaminergic adverse effects. Selepressin, a selective vasopressin V1a receptor agonist, is a noncatechola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d5b82b7047ddd06f57c2394ab000218
https://hal.umontpellier.fr/hal-02793704
https://hal.umontpellier.fr/hal-02793704
Autor:
Laterre, Pierre-François, Berry, Scott M, Blemings, Allan, Carlsen, Jan E, François, Bruno, Graves, Todd, Jacobsen, Karsten, Lewis, Roger J, Opal, Steven M, Perner, Anders, Pickkers, Peter, Russell, James A, Windeløv, Nis A, Yealy, Donald M, Asfar, Pierre, Bestle, Morten H, Muller, Grégoire, Bruel, Cédric, Brulé, Noëlle, Decruyenaere, Johan, Dive, Alain-Michel, Dugernier, Thierry, Krell, Kenneth, Lefrant, Jean-Yves, Megarbane, Bruno, Mercier, Emmanuelle, Mira, Jean-Paul, Quenot, Jean-Pierre, Rasmussen, Bodil Steen, Thorsen-Meyer, Hans-Christian, Vander Laenen, Margot, Vang, Marianne Lauridsen, Vignon, Philippe, Vinatier, Isabelle, Wichmann, Sine, Wittebole, Xavier, Kjølbye, Anne Louise, Angus, Derek C, SEPSIS-ACT Investigators
Publikováno v:
JAMA, Vol. 322, no. 15, p. 1476-1485 (2019)
BASE-Bielefeld Academic Search Engine
Laterre, P-F, Berry, S M, Blemings, A, Carlsen, J E, François, B, Graves, T, Jacobsen, K, Lewis, R J, Opal, S M, Perner, A, Pickkers, P, Russell, J A, Windeløv, N A, Yealy, D M, Asfar, P, Bestle, M H, Muller, G, Bruel, C, Brulé, N, Decruyenaere, J, Dive, A-M, Dugernier, T, Krell, K, Lefrant, J-Y, Megarbane, B, Mercier, E, Mira, J-P, Quenot, J-P, Rasmussen, B S, Thorsen-Meyer, H-C, Vander Laenen, M, Vang, M L, Vignon, P, Vinatier, I, Wichmann, S, Wittebole, X, Kjølbye, A L, Angus, D C, SEPSIS-ACT Investigators & Rasmussen, B S 2019, ' Effect of Selepressin vs Placebo on Ventilator-and Vasopressor-Free Days in Patients With Septic Shock : The SEPSIS-ACT Randomized Clinical Trial ', JAMA: The Journal of the American Medical Association, vol. 322, no. 15, pp. 1476-1485 . https://doi.org/10.1001/jama.2019.14607
BASE-Bielefeld Academic Search Engine
Laterre, P-F, Berry, S M, Blemings, A, Carlsen, J E, François, B, Graves, T, Jacobsen, K, Lewis, R J, Opal, S M, Perner, A, Pickkers, P, Russell, J A, Windeløv, N A, Yealy, D M, Asfar, P, Bestle, M H, Muller, G, Bruel, C, Brulé, N, Decruyenaere, J, Dive, A-M, Dugernier, T, Krell, K, Lefrant, J-Y, Megarbane, B, Mercier, E, Mira, J-P, Quenot, J-P, Rasmussen, B S, Thorsen-Meyer, H-C, Vander Laenen, M, Vang, M L, Vignon, P, Vinatier, I, Wichmann, S, Wittebole, X, Kjølbye, A L, Angus, D C, SEPSIS-ACT Investigators & Rasmussen, B S 2019, ' Effect of Selepressin vs Placebo on Ventilator-and Vasopressor-Free Days in Patients With Septic Shock : The SEPSIS-ACT Randomized Clinical Trial ', JAMA: The Journal of the American Medical Association, vol. 322, no. 15, pp. 1476-1485 . https://doi.org/10.1001/jama.2019.14607
Importance: Norepinephrine, the first-line vasopressor for septic shock, is not always effective and has important catecholaminergic adverse effects. Selepressin, a selective vasopressin V1a receptor agonist, is a noncatecholaminergic vasopressor tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26223cf5b4f4b453b7db6ea9a0c5cd5a
https://hdl.handle.net/2078.1/224967
https://hdl.handle.net/2078.1/224967
Autor:
Russell, James A, Vincent, Jean-Louis, Kjølbye, Anne Louise, Olsson, Håkan, Blemings, Allan, Spapen, Herbert, Carl, Peder, Laterre, Pierre-François, Grundemar, Lars
Publikováno v:
Critical care (London, England), Vol. 21, no.1, p. 213 [1-10] (2017)
BACKGROUND: Vasopressin is widely used for vasopressor support in septic shock patients, but experimental evidence suggests that selective V1A agonists are superior. The initial pharmacodynamic effects, pharmacokinetics, and safety of selepressin, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::f044a64b0f80cc4e6a179e8803d18511
https://hdl.handle.net/2078.1/200737
https://hdl.handle.net/2078.1/200737
Autor:
Russell, James, Jean-Louis Vincent, Kjølbye, Anne, Olsson, Håkan, Blemings, Allan, Spapen, Herbert, Carl, Peder, Pierre-Francois Laterre, Grundemar, Lars
Exclusion criteria. Table S2. Study drug discontinuation criteria. Table S3. Study drug weaning protocol. Table S4. Proportion of patients maintaining MAP >60 mmHg. Table S5. Pharmacokinetic parameters of selepressin in septic shock patients. Table S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc55e293e4dd51d2f40d8fa8437480e7